TENDERS & PROCUREMENT

Amendments and Corrigenda to DG ESIC Rate Contracts 154, 155, 156, 157, 158, 160, 161, 163, 166

By TEAM CIRCULAR EXPRESS • 13 Nov 2026
👁 3 views
• This document is a compilation of multiple amendments and corrigenda issued by the ESIC Headquarters regarding various DG ESIC Rate Contracts.
• It details revisions in drug prices, pack sizes, manufacturing site addresses, authorized signatory names, and the deletion of off-patent items from the approved list.
• These changes apply to various pharmaceutical firms including Novartis, AstraZeneca, and others.
purpose of issue
Amendments and corrigenda to existing DG ESIC Rate Contracts regarding drug procurement details.
is it guidelines or office order
Office Order
Most Important Details
The document contains multiple amendments issued between 2024 and 2026, covering price revisions, pack size changes, manufacturing site updates, and deletion of off-patent drugs from ESIC Rate Contracts 154-166.
Share

Regards, Circular Express

You are viewing
Amendments and Corrigenda to DG ESIC Rate Contracts 154, 155, 156, 157, 158, 160, 161, 163, 166

For Circular Express Members Only

Enter your registered 10-digit mobile number to view this circular.

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *